Feasibility StudiesInterdisciplinary CommunicationLung Neoplasms
Dr. Charles Marc Leyrer, MD
NPI1518301464PAC ID4486956695
- Medicare services, 2022
- 1,133
- Part D claims, 2024
- 45
- Publications
- 14
- Hospital affiliations
- 1
- Industry payments
- $35
- Practice address
- 201 - 16th Avenue East, Seattle, WA 98112
- Practice phone
- Call (206) 326-3000
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Leyrer's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Charles Marc Leyrer is a radiation oncologist in Seattle, Washington
Dr. Leyrer practices at Kaiser Permanente Central Hospital in Seattle, Washington, part of Kaiser Permanente.
Dr. Leyrer's NPI, 1518301464, was assigned on April 22, 2013. Dr. Leyrer holds North Carolina license 2018-01349.
NPI and contact details
- NPI
- 1518301464NPI Registry (opens in a new tab)
- Medicare PAC ID
- 4486956695
- NPI enumeration date
- April 22, 2013
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Practice phone
- (206) 326-3000
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 39
- Medical school graduation
- 2013
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Charles Marc Leyrer practices at Kaiser Permanente Central Hospital in Seattle, Washington
Dr. Leyrer's primary practice is Kaiser Permanente Central Hospital, at 201 - 16th Avenue East, Seattle, WA 98112 in King County. The practice phone is (206) 326-3000.
- Kaiser Permanente Central Hospital201 - 16th Avenue East, Seattle, WA 98112 · King CountyPhone(206) 326-3000
Source: Dmand AI Affiliation Data
Dr. Charles Marc Leyrer is affiliated with 2 sites of care and 1 medical group
Dr. Leyrer's primary practice is Kaiser Permanente Central Hospital in Seattle, Washington, part of Kaiser Permanente. The medical group on file is Washington Permanente Medical Group, P.C. Dmand AI also links Dr. Leyrer to 1 more group practice or clinic, named with a free account.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Charles Marc Leyrer's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Leyrer practices, 2 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Kaiser Permanente Central Hospital | Available with a free account |
| +1 more affiliated site | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every hospital where Dr. Leyrer practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across Kaiser Permanente and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Charles Marc Leyrer is one of 162 radiation oncologists in Washington
Radiation oncology is Dr. Leyrer's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Leyrer is licensed in North Carolina.
Specialties and state licenses
- Radiation oncology, North CarolinaPrimary
Radiation oncologists near Dr. Leyrer
Counts of radiation oncologists with a Dmand AI profile, by place and practice. Each opens the list.
162radiation oncologists in Washington66radiation oncologists in Seattle2radiation oncologists at Kaiser Permanente Central Hospital
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Charles Marc Leyrer billed Medicare for 1,133 services in 2022
CMS data shows 1,133 Medicare services from Dr. Leyrer across 14 procedure codes in 2022. Medicare paid $66,745 for them. Every service was in a facility, such as a hospital, rather than an office.
Medicare services, 20221,133
Paid by Medicare$66,745
Procedure codes14
Dr. Leyrer's Medicare services by type, 2021 to 2022
- 2021
- 2022
- Imaging
- 2021: 1,6542022: 56266%
- Other services
- 2021: 922022: 506450%
- Office and hospital visits
- 2021: 892022: 6527%
Dr. Leyrer compared with the Washington median for radiation oncologists, 2022
- Dr. Leyrer
- Washington median
- Medicare services
- 1,133vs 1,187Close to median
- Part D claims
- 20vs 4455% below
Medians across 156 radiation oncologists in Washington with Dmand AI profiles that report each measure.
Dr. Leyrer's most billed Medicare procedure codes, 2022
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Leyrer?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Leyrer and other radiation oncologists in Washington.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Charles Marc Leyrer's patients have a median age of 68
Across all payers, Dmand AI patient panel data puts Dr. Leyrer's median patient age at 68, with 0% women.
Dr. Leyrer's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 68
Patient panel by sex, all payers
- Women0%
- Men100%
Source: Dmand AI Patient Panel Data
Dr. Charles Marc Leyrer wrote 45 Medicare Part D claims in 2024
In 2024, Dr. Leyrer wrote 45 Medicare Part D claims for 26 patients. 96% of them were for generic drugs. CMS names the drug for 20 of them, across 1 drug with 11 or more claims each, at $256 in total drug cost. In 2023, CMS named 45 claims across 2 drugs.
Part D claims, 202445
Drugs named by CMS1
Total drug cost$256
Part D patients26
Dr. Leyrer's Part D claims by kind of drug, 2024
- Generic43 claims96%
- Brand-name and other2 claims4%
Dr. Leyrer's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 452024: 2056%
Drugs named by CMS: 1 in 2024, 2 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
How Dr. Charles Marc Leyrer takes part in Medicare
Dr. Leyrer accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
- Accepts Medicare assignment
- Yes
Source: Doctors and Clinicians National Downloadable File (CMS)
For MedTech and pharma teams
Find radiation oncologists like Dr. Leyrer by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Charles Marc Leyrer has 14 publications on record
Dmand AI links 14 papers to Dr. Leyrer, published from 2013 to 2023. 2019 was the busiest year, with 3. The most frequent topics are Brain Neoplasms, Glioma and Lung Neoplasms. Dr. Leyrer has published most often in Pract Radiat Oncol. Dr. Leyrer's most frequent co-authors are Ryan Thomas Hughes, Ehsan Hussain Balagamwala, MD and Gene Henry Barnett, MD.
Papers14
Years published2013 to 2023
Dr. Leyrer's papers by year, 2013 to 2023
Topics Dr. Leyrer writes about most
- Brain Neoplasms
- Glioma
- Lung Neoplasms
- Tumor Burden
- Brain
- Breast Neoplasms
- Isocitrate Dehydrogenase
- Neoplasm Metastasis
Dr. Leyrer's most frequent co-authors
- Ryan Thomas Hughes5 shared papers
- Ehsan Hussain Balagamwala, MD3 shared papers
- Gene Henry Barnett, MD3 shared papers
Recent publications by Dr. Leyrer
Carcinoma, Non-Small-Cell LungLung NeoplasmsRadiosurgery
Int J Radiat Oncol Biol Phys
Antineoplastic Agents, AlkylatingBrain NeoplasmsCell Transformation, Neoplastic
See who Dr. Leyrer researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Leyrer works with, so you can find a warm path to the right radiation oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Charles Marc Leyrer received $35 in industry payments from 2018 to 2021
CMS Open Payments shows 2 general payments to Dr. Leyrer from 2 drug and device companies from 2018 to 2021. Food and beverage make up the largest share, 100% of the total. Bristol-Myers Squibb Company paid the most, $20.
General payments to Dr. Leyrer by program year, 2018 to 2021
Companies that paid Dr. Leyrer the most, 2018 to 2021
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Charles Marc Leyrer's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Charles Marc Leyrer
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Charles Marc Leyrer's NPI number?
Dr. Charles Marc Leyrer's NPI number is 1518301464. It was assigned on April 22, 2013, and it is active in the NPI Registry.
What kind of doctor is Dr. Charles Marc Leyrer?
Dr. Charles Marc Leyrer is a radiation oncologist in Seattle, Washington. The primary specialty in the NPI Registry is Radiation Oncology Physician (taxonomy code 2085R0001X).
Where does Dr. Charles Marc Leyrer practice?
Dr. Leyrer practices at 201 - 16th Avenue East, Seattle, WA 98112. Dr. Leyrer's primary practice is Kaiser Permanente Central Hospital in Seattle, Washington, part of Kaiser Permanente. Dmand AI also links Dr. Leyrer to 1 group practice or clinic.
What is Dr. Charles Marc Leyrer's office phone number?
The practice phone on file for Dr. Leyrer is (206) 326-3000.
What is Dr. Charles Marc Leyrer's medical license number?
Dr. Leyrer holds North Carolina license 2018-01349.
Which hospitals is Dr. Charles Marc Leyrer affiliated with?
Dr. Leyrer practices at Kaiser Permanente Central Hospital in Seattle, Washington.
What medical group is Dr. Charles Marc Leyrer part of?
Dr. Leyrer is linked to Washington Permanente Medical Group, P.C.
Does Dr. Charles Marc Leyrer accept Medicare?
Yes. CMS data shows Dr. Leyrer billed Medicare for 1,133 services in 2022, and Dr. Leyrer accepts Medicare assignment.
What services does Dr. Charles Marc Leyrer bill to Medicare?
In 2022, Dr. Leyrer's most billed Medicare services were medicare service (G6002), radiation oncology (77427) and radiation oncology (77300).
What drugs does Dr. Charles Marc Leyrer prescribe most?
In 2024 Medicare Part D data, Dr. Leyrer's most prescribed drugs by claims were Tamsulosin HCl.
Show 4 more questionsShow fewer questions
Has Dr. Charles Marc Leyrer received payments from drug or device companies?
CMS Open Payments shows $35 in general payments to Dr. Leyrer from 2 companies from 2018 to 2021. The largest total came from Bristol-Myers Squibb Company.
How long has Dr. Charles Marc Leyrer been practicing?
Dr. Leyrer graduated from medical school in 2013, 13 years ago.
Does Dr. Charles Marc Leyrer do research?
Dmand AI links 14 publications to Dr. Leyrer, published from 2013 to 2023.
Who does Dr. Charles Marc Leyrer publish with?
Dr. Leyrer's most frequent co-authors are Ryan Thomas Hughes (5 shared papers), Ehsan Hussain Balagamwala, MD (3 shared papers) and Gene Henry Barnett, MD (3 shared papers).
Selling to radiation oncology practices?
See radiation oncologists in Washington by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card